The purpose of this paper was to evaluate the stability of naloxone and normaloxone in plasma and urine specimens.
Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry.
Fang WB, Chang Y, McCance-Katz EF, Moody DE
Purpose
Conclusion
Naloxone and normaloxone were stable in plasma and urine stored for 24 h at room temperature, 468 days at -20 degrees C, and through 3 freeze-thaw cycles. Naloxone was detected in plasma 0-4 h after administration, but not at any timepoint after 4 h, and normaloxone was not detected at any timepoint.
Studies (1)
Purpose
The purpose of this study was to determine the effects of storage and freeze-thaw cycling on naloxone and normaloxone concentrations in plasma and urine specimens. Specimens collection began immediately after administration of naloxone to patients which was considered to be time 0 h.
Summary of Findings
Naloxone and normaloxone were stable in plasma and urine during storage for 24 h at room temperature, 468 days at -20 degrees C, and through 3 freeze-thaw cycles. Naloxone was detected in plasma 0-4 h after administration, but not at any timepoint after 4 h, and normaloxone was not detected at any timepoint.
Biospecimens
FluidPlasmaFluidUrineFluidBloodPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
Small moleculeESI MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location PlasmaUrineBiospecimen Acquisition Time of biospecimen collection 0 h0.5 h1 h1.5 h12 h2 h24 h4 h6 h8 hStorage Freeze/thaw cycling 0 cycles3 cyclesStorage Storage duration 0 h17 h24 h468 daysStorage Storage temperature -20 degrees CRoom temperature